Tampa, FL – CompPharma, LLC, a consortium of workers’ compensation pharmacy benefit management (PBM) firms, voices continued support for New York State’s comprehensive drug reform package.
The new law contains provisions to overhaul the way potentially addictive or abused prescription drugs are tracked in the state and includes a “real time” prescription monitoring registry. Physicians and pharmacists will be required to view a patient’s controlled substance history on a secure web-based registry before they prescribe or dispense controlled substances.
“We applaud the state’s initiative in tackling the national epidemic of drug abuse,” said CompPharma’s President, Joseph Paduda. “The leadership of Attorney General Schneiderman and the heavy lifting by key members of the State Assembly and Senate will make this much-needed law reality. We’ve worked closely with many elected officials to help promote I-STOP; their willingness to invest time and energy in I-STOP shows the importance of the issue.
This is a major issue in workers’ comp, as claimants may receive several prescriptions for pain killers and muscle relaxants. This law gives workers’ compensation physicians access to information about controlled substances their patients are already taking, which will help prevent harmful drug-to-drug interactions, abuse, overdoses and diversion.”
In addition to the Internet System for Tracking Over-Prescribing (I-Stop), the law mandates electronic prescribing of controlled substances to eliminate diversion through the alteration, forgery or theft of prescription paper. It will also update the controlled substance schedule, moving Hydrocodone from Schedule III to Schedule II regardless of its formulation. This will eliminate automatic refills and limit the amount dispensed to a maximum 30-day supply. Hydrocodone is the most commonly prescribed drug in workers’ compensation.
Additionally the law calls for greater education of physicians on the dangers of controlled substances and programs for the safe disposal of un-used prescriptions.
Source: King Knight / CompPharma